查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829821

2025年全球腫瘤消融市場報告

Tumor Ablation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腫瘤消融市場規模迅速擴張，從2024年的14.5億美元成長至2025年的16.2億美元，複合年成長率達11.7%。預測期內的成長歸因於更精準、更有效率的消融技術的發展、新興經濟體醫療保健支出的增加、人口老化趨勢、癌症負擔的增加以及全球癌症盛行率的上升。

預計未來幾年腫瘤消融市場將快速成長，到2029年將達到24.7億美元，複合年成長率為11.1%。預測期內的成長歸因於癌症盛行率的上升、微創手術的使用增加、應用範圍的拓展、醫療保健成本效益的提高以及認知度和教育水平的提高。預測期內的主要趨勢包括技術進步、先進消融技術的持續發展、人工智慧的整合、對門診病人環境的關注以及以患者為中心的診療方法。

腫瘤消融是一種微創醫療手術，旨在透過直接向腫瘤施加極熱、極冷或化學藥物來殺死細胞，從而去除癌組織。這種方法通常用於治療小腫瘤或位於複雜解剖位置的腫瘤。

腫瘤消融的主要類型包括熱消融和化學消融。熱感消融利用極高的熱量破壞異常或病變組織，並用於各種經皮、經皮和外科手術治療，治療乳癌、肝癌、乳癌、肺癌和攝護腺癌等疾病。這些技術的最終用戶包括醫院、腫瘤中心和其他醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供腫瘤消融市場統計數據，包括全球市場規模、區域佔有率、腫瘤消融市場佔有率的競爭對手、詳細的腫瘤消融細分市場、市場趨勢和商業機會，以及在腫瘤消融行業取得成功所需的數據。本腫瘤消融市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整展望。

未來五年的預測成長率為11.1%，較我們先前對該市場的預測略有下降0.7%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，導致來自英國和新加坡等主要地區的冷凍消融探針和射頻發生器模組的供應鏈中斷，從而導致治療延遲和腫瘤治療費用增加。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

隨著微創手術的日益普及，腫瘤消融市場預計將迎來成長。微創手術是指無需切口或僅需小切口的醫療或外科手術干預，與傳統手術相比，其優點包括恢復時間更快、併發症風險更低以及術後疼痛減輕。這些手術採用射頻、微波或冷凍消融等腫瘤消融技術，在破壞癌組織的同時，最大限度地減少對周圍健康組織的損傷，從而進一步縮短患者恢復時間。例如，Intuitive Surgical Inc. 報告稱，其支持微創手術的達文西手術系統在 2023 年第四季度的安裝量較 2022 年成長了 12%，這進一步支撐了微創手術的發展勢頭，從而促進了腫瘤消融市場的成長。

腫瘤消融市場的主要企業正專注於技術創新，以提高治療效果並擴大可治療腫瘤的範圍。創新領域之一是開發骨腫瘤消融系統等專用產品。這些系統專為治療骨腫瘤的微創手術而設計。美敦力公司（Medtronic plc）的OsteoCool 2.0骨腫瘤消融系統於2024年3月獲得FDA 510(k)批准。這款升級版系統專為治療疼痛性骨轉移瘤和良性骨腫瘤（例如骨樣骨瘤）而設計。能夠同時使用四個內部冷卻探頭，提高了治療的靈活性。此系統的高功率同類系統，例如Stryker OptaBlate™骨腫瘤消融系統。

2022年12月，美國生物醫藥製造公司波士頓科學公司（Boston Scientific Corporation）以5.23億美元收購了艾科泰克科技控股有限公司（Acotec Scientific Holdings Ltd.）。此次收購將增強波士頓科學公司在中國的業務，並在全球實現艾科泰克科技產品系列的商業化。艾科泰克科技控股有限公司是一家專注於射頻消融術技術、藥物塗層球囊和血栓抽吸導管的中國醫療科技公司。

腫瘤消融市場包括提供諮詢、診斷、化學消融和術後護理等服務的營業單位所獲得的收益。市場價值還包括服務提供者銷售或包含在服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤消融：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球腫瘤消融市場：成長率分析
  • 全球腫瘤消融市場表現：規模與成長，2019-2024
  • 全球腫瘤消融市場預測：規模與成長，2024-2029年，2034年
  • 全球腫瘤消融：總目標市場（TAM）

第6章 市場細分

  • 全球腫瘤消融市場：按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 熱消融
  • 化學消融
  • 全球腫瘤消融市場（按治療類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 經皮
  • 腹腔鏡
  • 外科手術
  • 全球腫瘤消融市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 腎癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 其他癌症
  • 全球腫瘤消融市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 腫瘤中心
  • 其他最終用戶
  • 全球腫瘤消融市場：按熱消融類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術（RFA）
  • 微波消融（MWA）
  • 冷凍療法
  • 雷射消熔
  • 高強度聚焦超音波（HIFU）
  • 全球腫瘤消融市場：按化學消融類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 乙醇消融
  • 醋酸消融
  • 基於化療的消融術（化療栓塞術）

第7章 區域和國家分析

  • 全球腫瘤消融市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腫瘤消融市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 腫瘤消融市場：競爭格局
  • 腫瘤消融市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Olympus Corporation
  • Terumo Corporation
  • Varian Medical Systems Inc.
  • Merit Medical Systems Inc.
  • Bioventus LLC
  • Accuray Incorporated
  • AtriCure Inc.
  • AngioDynamics Inc.
  • EDAP TMS SA
  • NeuWave Medical Inc.
  • Mirabilis Medical Inc.
  • STARMed Co. Ltd.
  • Profound Medical Corp.
  • RF Medical Co. Ltd.
  • IceCure Medical Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年腫瘤消融市場：提供新機會的國家
  • 2029年腫瘤消融市場：細分領域帶來新機會
  • 2029年腫瘤消融市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31428u

Tumor ablation is a minimally invasive medical procedure designed to eliminate cancerous tissues by applying extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This approach is commonly used for treating small tumors or those located in challenging anatomical locations.

The primary types of tumor ablation include thermal ablation and chemical ablation. Thermal ablation involves using extreme heat to destroy abnormal or diseased tissue, and it is employed across various treatments such as percutaneous, laparoscopic, and surgical procedures for conditions such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, among others. End users of these techniques include hospitals, oncology centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tumor ablation market research report is one of a series of new reports from The Business Research Company that provides tumor ablation market statistics, including the tumor ablation industry's global market size, regional shares, competitors with a tumor ablation market share, detailed tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation industry. This tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tumor ablation market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to the development of more precise and efficient ablation techniques, rising healthcare expenditure across emerging economies, the demographic shift towards older populations, the increasing burden of cancer, and the rising prevalence of cancer globally.

The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.47 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing cancer incidence, growing minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and growing awareness and education. Major trends in the forecast period include technological advancements, Continued development of advanced ablation technologies, integration of artificial intelligence, focus on outpatient settings, and patient-centric approaches.

The forecast of 11.1% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for cryoablation probes and radiofrequency generator modules, sourced from key regions such as the United Kingdom and Singapore, could lead to treatment postponements and increased oncology procedure expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The tumor ablation market is poised for growth due to the increasing adoption of minimally invasive procedures. Minimally invasive procedures involve medical or surgical interventions that require small incisions or no incisions at all, driven by their benefits such as reduced recovery times, lower complication risks, and less post-operative pain compared to traditional surgeries. Tumor ablation techniques, including radiofrequency, microwave, or cryoablation, are employed in these procedures to destroy cancerous tissues while minimizing damage to surrounding healthy tissue, further contributing to quicker recovery times. For example, Intuitive Surgical Inc. reported a 12% increase in placements of da Vinci surgical systems, which facilitate minimally invasive approaches, in the fourth quarter of 2023 compared to 2022, underscoring the momentum behind minimally invasive procedures and, consequently, the tumor ablation market's growth.

Leading companies in the tumor ablation market are focusing on innovation to enhance treatment effectiveness and broaden the scope of treatable tumors. One area of innovation is the development of specialized products such as bone tumor ablation systems. These systems are designed specifically for minimally invasive procedures to treat bone tumors. Recently, Medtronic plc received FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system in March 2024. This upgraded system is tailored for treating painful bone metastases and benign bone tumors such as osteoid osteoma. It allows for the simultaneous use of four internally cooled probes, offering greater flexibility in treatment. The system delivers enhanced power, significantly exceeding that of comparable systems such as the Stryker OptaBlateTM bone tumor ablation system.

In December 2022, Boston Scientific Corporation, a US-based biomedical manufacturing company, acquired Acotec Scientific Holdings Ltd. for $523 million. Through this acquisition, Boston Scientific aims to enhance its presence in China and globally commercialize the product portfolio of Acotec Scientific. Acotec Scientific Holdings Ltd., a China-based medical technology company, specializes in radiofrequency ablation technologies, drug-coated balloons, and thrombus aspiration catheters.

Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Thermal Ablation; Chemical Ablation
  • 2) By Types Of Treatment: Percutaneous; Laparoscopic; Surgical
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Cancer
  • 4) By End Users: Hospitals; Oncology Centers; Other End Users
  • Subsegments:
  • 1) By Thermal Ablation: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
  • 2) By Chemical Ablation: Ethanol Ablation; Acetic Acid Ablation; Chemotherapy-Based Ablation (Chemoembolization)
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Varian Medical Systems Inc.; Merit Medical Systems Inc.; Bioventus LLC; Accuray Incorporated; AtriCure Inc.; AngioDynamics Inc.; EDAP TMS S.A.; NeuWave Medical Inc.; Mirabilis Medical Inc.; STARMed Co. Ltd.; Profound Medical Corp.; RF Medical Co. Ltd.; IceCure Medical Ltd.; MedWaves Inc.; Chongqing Haifu Medical Technology Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Market Characteristics

3. Tumor Ablation Market Trends And Strategies

4. Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Ablation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Ablation Market Growth Rate Analysis
  • 5.4. Global Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Ablation Total Addressable Market (TAM)

6. Tumor Ablation Market Segmentation

  • 6.1. Global Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thermal Ablation
  • Chemical Ablation
  • 6.2. Global Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Percutaneous
  • Laparoscopic
  • Surgical
  • 6.3. Global Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer
  • 6.4. Global Tumor Ablation Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Oncology Centers
  • Other End Users
  • 6.5. Global Tumor Ablation Market, Sub-Segmentation Of Thermal Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Cryoablation
  • Laser Ablation
  • High-Intensity Focused Ultrasound (HIFU)
  • 6.6. Global Tumor Ablation Market, Sub-Segmentation Of Chemical Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ethanol Ablation
  • Acetic Acid Ablation
  • Chemotherapy-Based Ablation (Chemoembolization)

7. Tumor Ablation Market Regional And Country Analysis

  • 7.1. Global Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Market

  • 8.1. Asia-Pacific Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Market

  • 9.1. China Tumor Ablation Market Overview
  • 9.2. China Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Market

  • 10.1. India Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Market

  • 11.1. Japan Tumor Ablation Market Overview
  • 11.2. Japan Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Market

  • 12.1. Australia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Market

  • 13.1. Indonesia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Market

  • 14.1. South Korea Tumor Ablation Market Overview
  • 14.2. South Korea Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Market

  • 15.1. Western Europe Tumor Ablation Market Overview
  • 15.2. Western Europe Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Market

  • 16.1. UK Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Market

  • 17.1. Germany Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Market

  • 18.1. France Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Market

  • 19.1. Italy Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Market

  • 20.1. Spain Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Market

  • 21.1. Eastern Europe Tumor Ablation Market Overview
  • 21.2. Eastern Europe Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Market

  • 22.1. Russia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Market

  • 23.1. North America Tumor Ablation Market Overview
  • 23.2. North America Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Market

  • 24.1. USA Tumor Ablation Market Overview
  • 24.2. USA Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Market

  • 25.1. Canada Tumor Ablation Market Overview
  • 25.2. Canada Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Market

  • 26.1. South America Tumor Ablation Market Overview
  • 26.2. South America Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Market

  • 27.1. Brazil Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Market

  • 28.1. Middle East Tumor Ablation Market Overview
  • 28.2. Middle East Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Market

  • 29.1. Africa Tumor Ablation Market Overview
  • 29.2. Africa Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Ablation Market Competitive Landscape
  • 30.2. Tumor Ablation Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Market Other Major And Innovative Companies

  • 31.1. Olympus Corporation
  • 31.2. Terumo Corporation
  • 31.3. Varian Medical Systems Inc.
  • 31.4. Merit Medical Systems Inc.
  • 31.5. Bioventus LLC
  • 31.6. Accuray Incorporated
  • 31.7. AtriCure Inc.
  • 31.8. AngioDynamics Inc.
  • 31.9. EDAP TMS S.A.
  • 31.10. NeuWave Medical Inc.
  • 31.11. Mirabilis Medical Inc.
  • 31.12. STARMed Co. Ltd.
  • 31.13. Profound Medical Corp.
  • 31.14. RF Medical Co. Ltd.
  • 31.15. IceCure Medical Ltd.

32. Global Tumor Ablation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Market

34. Recent Developments In The Tumor Ablation Market

35. Tumor Ablation Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Ablation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Ablation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Ablation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer